Hersey Peter, Poullis Mike
Department of Anaesthesia, Sunderland Royal Hospital, Sunderland, UK.
Interact Cardiovasc Thorac Surg. 2008 Oct;7(5):906-9. doi: 10.1510/icvts.2008.184010. Epub 2008 Jul 24.
A best evidence topic in cardiovascular surgery was written according to a structured protocol. The question addressed was whether mannitol might prevent renal failure in patients undergoing open repair of an abdominal aortic aneurysm. Altogether more than 25 papers were found using the reported search, of which eight represented the best evidence to answer the clinical question. In total, 319 patients were included in these eight studies. Five of the included studies date from 1961-1965, and the remaining three from 1986, 1996 and 2002. The age of study is reflected in the level of evidence presented. The three recent studies provide evidence at a level of 1b, the remaining five giving evidence only at level 3b or 4. Of note also is that the earlier studies used urine output as their main indicator of renal failure in reaching their conclusions. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude that no clinical trials to date have demonstrated any clinical reduction in the incidence of renal failure in patients undergoing repair of an abdominal aortic aneurysm who have been given mannitol.
一篇心血管外科领域的最佳证据主题文章是按照结构化方案撰写的。所探讨的问题是,甘露醇是否能预防接受腹主动脉瘤开放修复术患者的肾衰竭。通过报告的检索方式共找到25余篇论文,其中8篇代表了回答该临床问题的最佳证据。这8项研究共纳入319例患者。纳入的研究中有5项来自1961年至1965年,其余3项分别来自1986年、1996年和2002年。研究的年代反映在其所提供证据的水平上。最近的3项研究提供的证据等级为1b,其余5项仅提供3b或4级证据。同样值得注意的是,早期研究在得出结论时将尿量作为肾衰竭的主要指标。现将这些论文的作者、期刊、发表日期、国家、研究的患者组、研究类型、相关结局和结果制成表格。我们得出结论,迄今为止,尚无临床试验表明,接受腹主动脉瘤修复术且使用甘露醇的患者,其肾衰竭发生率有任何临床意义上的降低。